Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: May 13, 2025
Open Peer Review Period: May 21, 2025 - Jul 16, 2025
Date Accepted: Nov 8, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Diagnostic Accuracy, Implementation Barriers, and Equity Implications of Teledermatology in Rural Skin Cancer: Scoping Review

Parga AD, Peng DS, Vu TN, Kizy SM, Khan A

Diagnostic Accuracy, Implementation Barriers, and Equity Implications of Teledermatology in Rural Skin Cancer: Scoping Review

JMIR Dermatol 2025;8:e77443

DOI: 10.2196/77443

PMID: 41461110

PMCID: 12747661

Teledermatology in Rural Skin Cancer Care: A Literature Review of Diagnostic Accuracy, Implementation Barriers, and Equity Implications

  • Andres D Parga; 
  • Dorothy S Peng; 
  • Toan N Vu; 
  • Selene M Kizy; 
  • Aisha Khan

ABSTRACT

Background:

Skin cancer is the most commonly diagnosed malignancy in the United States, with rural populations facing disproportionate delays in diagnosis due to geographic isolation, workforce shortages, and limited access to dermatologic care. These delays contribute to higher rates of late-stage diagnosis and poorer outcomes. Teledermatology has emerged as a promising solution to expand access to dermatologic evaluation and treatment in underserved settings.

Objective:

To evaluate the diagnostic performance, implementation challenges, and equity considerations of teledermatology in the context of rural skin cancer care, and to assess its potential to improve clinical outcomes in underserved populations.

Methods:

A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar to identify studies published between January 2015 and March 2025. Search terms included “teledermatology,” “skin cancer,” “rural health services,” “telemedicine,” “diagnostic accuracy,” and “health disparities.” Studies evaluating diagnostic metrics, time to diagnosis, patient satisfaction, and implementation barriers were included.

Results:

Nine key studies spanning various countries and healthcare settings were included. Diagnostic sensitivity ranged from 41.9% to 100%, and specificity from 46% to 90%, depending on modality and lesion type. Teledermatology consistently reduced time to diagnosis, in some cases by over 75%, and was associated with high patient satisfaction due to increased convenience and reduced travel. Key barriers included technological limitations, inconsistent imaging protocols, and reimbursement variability. Successful implementation was facilitated by standardized workflows, dermoscopy integration, and centralized platforms.

Conclusions:

Teledermatology is a viable and effective approach to addressing disparities in rural skin cancer care. It offers diagnostic accuracy comparable to face-to-face evaluations while reducing wait times and improving patient satisfaction. Overcoming technological and systemic barriers is critical to ensuring equitable, long-term integration of teledermatology in rural health systems.


 Citation

Please cite as:

Parga AD, Peng DS, Vu TN, Kizy SM, Khan A

Diagnostic Accuracy, Implementation Barriers, and Equity Implications of Teledermatology in Rural Skin Cancer: Scoping Review

JMIR Dermatol 2025;8:e77443

DOI: 10.2196/77443

PMID: 41461110

PMCID: 12747661

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.